APA (7th ed.) Citation

A, A., A, A., EE, C., F, M., J, C., P, D., . . . Jr, P. C. (2023). Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study. Advances in therapy, 40(6), 2886. https://doi.org/10.1007/s12325-023-02518-w

Chicago Style (17th ed.) Citation

A, Agiro, An A, Cook EE, Mu F, Chen J, Desai P, Oluwatosin Y, and Pollack CV Jr. "Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study." Advances in Therapy 40, no. 6 (2023): 2886. https://doi.org/10.1007/s12325-023-02518-w.

MLA (9th ed.) Citation

A, Agiro, et al. "Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study." Advances in Therapy, vol. 40, no. 6, 2023, p. 2886, https://doi.org/10.1007/s12325-023-02518-w.